ANNUAL REPORT 2002

 

BIOPURE CORPORATION

TABLE OF CONTENTS:  




Page 15 of 20      < Previous     Next >  


Consolidated Balance Sheets

October 31,
 

 

2002

 

2001
(In thousands, except share and per
share data)
ASSETS
Current assets:
   Cash and cash equivalents $ 19,710   $ 36,089  
   Accounts receivable, less allowance of $8 and $40 at October 31, 2002 and 2001, respectively 89   724  
   Inventories, net 8,028   4,665  
   Other current assets 709   771  
      Total current assets 28,536   42,249  
Property, plant and equipment:
   Land 401   262  
   Equipment 36,436   30,252  
   Leasehold improvements 15,884   14,207  
   Furniture and fixtures 1,025   973  
   Construction in progress 500   2,976  
   New facility construction 12,757   5,205  
  67,003   53,875  
   Accumulated depreciation and amortization (28,234)   (23,713)  
Net property, plant and equipment 38,769   30,162  
Investment in affiliate ---   32  
Deposit on new facility 10,000   10,000  
Other assets 972   1,744  
      Total assets $ 78,277   $ 84,187  
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
   Accounts payable $ 2,163   $ 1,348  
   Accrued expenses 4,026  4,949  
      Total current liabilities 6,189   6,297  
Long-term liabilities:
Long-term debt 9,847   5,205  
Deferred compensation 184   1,792  
      Total long-term liabilities 10,031   6,997  
Commitments and contingencies, Notes 7 and 11.
Stockholders' equity:
   Preferred stock, $0.01 par value, 30,000,000 shares authorized, no shares outstanding ---   ---  
   Common stock:
      Class A, $0.01 par value, 100,000,000 shares authorized, 30,353,370 and 25,225,083
         shares issued and outstanding at October 31, 2002 and 2001, respectively
304   252  
      Class B, $1.00 par value, 179 shares authorized, 117.7 shares issued and outstanding ---   ---  
Capital in excess of par value 419,065   383,570  
Contributed capital 24,574   24,574  
Notes receivable from stockholders (255)   (1,655)  
Accumulated deficit (381,631)   (335,848)  
         Total stockholders' equity 62,057   70,893  
         Total liabilities and stockholders' equity $ 78,277   $ 84,187  

See accompanying notes.





Page 15 of 20      < Previous     Next >